Age at Diagnosis of Type 2 Diabetes and Depressive Symptoms, Diabetes-Specific Distress, and Self-Compassion.

"Duality of Interest. M.J.D. has acted as consultant, advisory board member, and speaker for Boehringer Ingelheim, Eli Lilly and Company, Novo Nordisk, and Sanofi; an advisory board member and speaker for AstraZeneca; an advisory board member for Janssen, Lexicon, Pfizer, and ShouTi Pharma Inc; and as a speaker for Napp Pharmaceuticals Ltd., Novartis Pharmaceuticals, and Takeda Pharmaceuticals International Inc.; and has received grants in support of investigator and investigator-initiated trials from Novo Nordisk, Sanofi, Eli Lilly and Company, Boehringer Ingelheim, AstraZeneca, and Janssen. K.K. has acted as consultant, advisory board member, and speaker for Abbott Laboratories, Amgen, AstraZeneca, Bayer, Napp Pharmaceuticals Ltd., Eli Lilly and Company, Merck Sharp & Dohme, Novartis Pharmaceuticals, Novo Nordisk, Roche, Berlin-Chemie AG/Menarini Group, Sanofi, Servier Pharmaceuticals, Boehringer Ingelheim; and has received European Academy of Continuing Medical Education grants from Boehringer Ingelheim, AstraZeneca, Novartis Pharmaceuticals, Novo Nordisk, Sanofi, Eli Lilly and Company, Merck Sharp & Dohme, and Servier Pharmaceuticals. T.Y. and J.A.S. are supported by the NIHR Leicester Biomedical Research Centre and have received project funding in the form of an investigator-initiated grant from AstraZeneca."

"Funding. This study was supported by the National Institute for Health and Care Research (NIHR) under its Programme Grants for Applied Research (NIHR201165), as well as by the NIHR Leicester Biomedical Research Centre and the NIHR Applied Research Collaboration East Midlands."